122 related articles for article (PubMed ID: 28900820)
1. Outcome of childhood leukaemia survivors and necrosis of the femoral head treated with autologous mesenchymal stem cells.
de Rojas T; Martínez-Álvarez S; Lerma-Lara S; Díaz MÁ; Madero L; Ramírez M
Clin Transl Oncol; 2018 May; 20(5):584-590. PubMed ID: 28900820
[TBL] [Abstract][Full Text] [Related]
2. Decreased Osteogenic Activity of Mesenchymal Stem Cells in Patients With Corticosteroid-Induced Osteonecrosis of the Femoral Head.
Houdek MT; Wyles CC; Packard BD; Terzic A; Behfar A; Sierra RJ
J Arthroplasty; 2016 Apr; 31(4):893-8. PubMed ID: 26404846
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem Cell Therapy for Bone Repair of Human Hip Osteonecrosis with Bilateral Match-Control Evaluation: Impact of Tissue Source, Cell Count, Disease Stage, and Volume Size on 908 Hips.
Hernigou P; Homma Y; Hernigou J; Flouzat Lachaniette CH; Rouard H; Verrier S
Cells; 2024 May; 13(9):. PubMed ID: 38727312
[TBL] [Abstract][Full Text] [Related]
4. Avascular necrosis of the femoral head in patients treated for leukaemia. Assessment of the need for a diagnostic protocol.
Alguacil Pinel J; Vila Vives P; Salom Taverner M
Rev Esp Cir Ortop Traumatol; 2017; 61(5):331-338. PubMed ID: 28728961
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.
Daltro GC; Fortuna V; de Souza ES; Salles MM; Carreira AC; Meyer R; Freire SM; Borojevic R
Stem Cell Res Ther; 2015 May; 6(1):110. PubMed ID: 26021713
[TBL] [Abstract][Full Text] [Related]
6. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively.
Tomaru Y; Yoshioka T; Sugaya H; Aoto K; Wada H; Akaogi H; Yamazaki M; Mishima H
BMC Musculoskelet Disord; 2017 Jul; 18(1):292. PubMed ID: 28683795
[TBL] [Abstract][Full Text] [Related]
7. Treatment of AVN using the induction chamber technique and a biological-based approach: indications and clinical results.
Calori GM; Mazza E; Colombo M; Mazzola S; Mineo GV; Giannoudis PV
Injury; 2014 Feb; 45(2):369-73. PubMed ID: 24119830
[TBL] [Abstract][Full Text] [Related]
8. Autologous adipose tissue-derived stem cells induce persistent bone-like tissue in osteonecrotic femoral heads.
Pak J
Pain Physician; 2012; 15(1):75-85. PubMed ID: 22270740
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia.
Riccio I; Pota E; Marcarelli M; Affinita MC; Di Pinto D; Indolfi C; Del Regno N; Esposito M
Pediatr Med Chir; 2016 Nov; 38(3):118. PubMed ID: 28009137
[TBL] [Abstract][Full Text] [Related]
10. Stage-related results in treatment of hip osteonecrosis with core-decompression and autologous mesenchymal stem cells.
Persiani P; De Cristo C; Graci J; Noia G; Gurzì M; Villani C
Acta Orthop Belg; 2015 Sep; 81(3):406-12. PubMed ID: 26435234
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of bone diseases with cell therapy].
Gangji V
Bull Mem Acad R Med Belg; 2011; 166(5-6):202-5; discussion 206-8. PubMed ID: 22891449
[TBL] [Abstract][Full Text] [Related]
12. Avascular necrosis of the femoral head in children with acute lymphoblastic leukemia: a 4- to 9-year follow-up study.
Madadi F; Shamsian BS; Alavi S; Madadi F; Eajazi A; Aslani A
Orthopedics; 2011 Oct; 34(10):e593-7. PubMed ID: 21956050
[TBL] [Abstract][Full Text] [Related]
13. Tissue-engineered approach for the treatment of steroid-induced osteonecrosis of the femoral head: transplantation of autologous mesenchymal stem cells cultured with beta-tricalcium phosphate ceramics and free vascularized fibula.
Kawate K; Yajima H; Ohgushi H; Kotobuki N; Sugimoto K; Ohmura T; Kobata Y; Shigematsu K; Kawamura K; Tamai K; Takakura Y
Artif Organs; 2006 Dec; 30(12):960-2. PubMed ID: 17181837
[TBL] [Abstract][Full Text] [Related]
14. History of concentrated or expanded mesenchymal stem cells for hip osteonecrosis: is there a target number for osteonecrosis repair?
Hernigou P; Guerin G; Homma Y; Dubory A; Chevallier N; Rouard H; Flouzat Lachaniette CH
Int Orthop; 2018 Jul; 42(7):1739-1745. PubMed ID: 29796764
[TBL] [Abstract][Full Text] [Related]
15. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids.
Kaste SC; Pei D; Cheng C; Neel MD; Bowman WP; Ribeiro RC; Metzger ML; Bhojwani D; Inaba H; Campbell P; Rubnitz JE; Jeha S; Sandlund JT; Downing JR; Relling MV; Pui CH; Howard SC
J Clin Oncol; 2015 Feb; 33(6):610-5. PubMed ID: 25605853
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and osteogenesis in rabbit femoral head osteonecrosis.
Fan L; Zhang C; Yu Z; Shi Z; Dang X; Wang K
Bone; 2015 Dec; 81():544-553. PubMed ID: 26363339
[TBL] [Abstract][Full Text] [Related]
17. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. Surgical technique.
Gangji V; Hauzeur JP
J Bone Joint Surg Am; 2005 Mar; 87 Suppl 1(Pt 1):106-12. PubMed ID: 15743852
[TBL] [Abstract][Full Text] [Related]
18. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells.
Zhao D; Cui D; Wang B; Tian F; Guo L; Yang L; Liu B; Yu X
Bone; 2012 Jan; 50(1):325-30. PubMed ID: 22094904
[TBL] [Abstract][Full Text] [Related]
19. [Femur head necrosis in haemophilia and after prolonged steroid therapy--description of two cases].
Kandzierski G; Gregosiewicz A; Małek U; Drabko K; Filiks-Litwin B; Latalski M
Chir Narzadow Ruchu Ortop Pol; 2004; 69(4):269-71. PubMed ID: 15587383
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of early osteonecrosis of femoral head by core decompression and autograft of mesenchymal stem cell cultured in vitro under arthroscopy: experiment with rabbits].
Cui DP; Zhao DW
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):338-41. PubMed ID: 19563714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
